Short interest in Rapport Therapeutics Inc (NASDAQ:RAPP) increased during the last reporting period, rising from 1.79M to 1.81M. This put 5.38% of the company's publicly available shares short.

Short interest for Rapport Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Rapport Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 143.53K shares traded per day, it would take 12.6 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.